425: Strive, Semler Scientific Announce Merger Plan

Strive, Inc. and Semler Scientific, Inc. have announced a proposed business combination, with Strive issuing Class A common stock.

Summary

• Strive, Inc. and Semler Scientific, Inc. are pursuing a proposed business combination.
• The communication regarding this proposed transaction was posted on X.com by Strive's CEO, CLO, and CFO on September 22, 2025.
• The transaction involves Strive issuing additional shares of its Class A common stock.
• A Registration Statement on Form S-4, including an Information Statement/Proxy Statement/Prospectus, will be filed with the SEC to register the Class A common stock and seek Semler Scientific stockholder approval.
• The filing includes extensive cautionary statements regarding forward-looking statements and associated risks.

Sentiment

Score: 7

Explanation: The filing announces a strategic business combination, which is generally a positive corporate development aimed at growth and synergy. While it contains extensive risk disclosures typical of such filings, the underlying intent of the merger suggests a forward-looking positive move.

Positives

• The proposed transaction is expected to yield strategic benefits for the combined company.
• Anticipated financial benefits are expected from the proposed transaction.
• Potential for successful integration of the combined businesses.

Negatives

• Potential for the proposed transaction to not close as expected or at all.
• Risk that anticipated benefits, including cost savings and strategic gains, may not be realized.
• Integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated.
• Diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock.
• Potential adverse reactions from customers or changes to business/employee relationships due to the announcement or completion of the transaction.
• Changes in Strive's or Semler Scientific's share price before closing could be adverse.

Risks

• Occurrence of any event, change, or circumstance that could lead to termination of the merger agreement.
• Conditions to closing the transaction may not be received or satisfied on a timely basis or at all.
• Outcome of any legal proceedings instituted against Strive, Semler Scientific, or the combined company.
• Anticipated benefits, including cost savings and strategic gains, may not be realized due to changes in or problems arising from Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement could negatively impact the combined company.
• Integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated.
• Diversion of management's attention from ongoing business operations and opportunities.
• Dilution for existing Strive shareholders due to the issuance of new Class A common stock.
• Potential adverse reactions of customers or changes to business or employee relationships.
• Changes in Strive's or Semler Scientific's share price before closing.

Future Outlook

The outlook includes expectations for strategic and financial benefits from the proposed business combination, the successful integration of the combined businesses, and the impact on the combined company's future financial performance. However, these are forward-looking statements subject to significant risks and uncertainties.

Management Comments

• Strive's Chief Executive Officer Matthew Cole, Chief Legal Officer Logan Beirne, and Chief Financial Officer Ben Pham posted a communication on X.com on September 22, 2025, regarding the proposed business combination with Semler Scientific.

Industry Context

This announcement signifies a consolidation event within the market, potentially driven by strategic alignment or growth objectives. The mention of Bitcoin treasury strategies and digital asset risks suggests a company operating in or expanding into areas influenced by cryptocurrency trends, which is a notable development in the broader financial and tech industries.

Legal Proceedings

• The possibility of legal proceedings being instituted against Strive or Semler Scientific or the combined company related to the proposed transaction.

Related Party Transactions

• Semler Scientific's definitive proxy statement for its 2025 Annual Meeting of Stockholders includes information on 'TRANSACTIONS WITH RELATED PERSONS'.

Stakeholder Impact

• Shareholders of Strive will experience dilution due to the issuance of new Class A common stock.
• Semler Scientific stockholders will need to approve the proposed transaction.
• Customers and employees of both companies may experience changes to business or employee relationships.
• The combined company's future financial performance will impact investors and creditors.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC.
• The Registration Statement will include an Information Statement/Proxy Statement/Prospectus.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval of the proposed transaction.
• Investors and stockholders are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus when they become available.

Key Dates

Recommendation

This filing is an initial announcement of a proposed business combination and primarily contains cautionary statements and procedural information. It lacks detailed financial projections or a comprehensive valuation of the combined entity. A seasoned investor would typically 'hold' their position, awaiting the full Registration Statement on Form S-4 and the Information Statement/Proxy Statement/Prospectus, which will provide more comprehensive financial and strategic details necessary for a definitive investment decision. The potential for dilution and integration risks also warrants a cautious approach.

Keywords

Strive Inc., Semler Scientific Inc., Merger, Acquisition, Business Combination, SEC Filing, Form 425, Corporate Governance, Risk Management, Bitcoin, Digital Assets